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ABSTRACT The transcriptional coactivator Sub1 has been implicated in several steps of 
mRNA metabolism in yeast, such as the activation of transcription, termination, and 3′-end 
formation. In addition, Sub1 globally regulates RNA polymerase II phosphorylation, and most 
recently it has been shown that it is a functional component of the preinitiation complex. 
Here we present evidence that Sub1 plays a significant role in transcription elongation by 
RNA polymerase II (RNAPII). We show that SUB1 genetically interacts with the gene encoding 
the elongation factor Spt5, that Sub1 influences Spt5 phosphorylation of the carboxy-terminal 
domain of RNAPII largest subunit by the kinase Bur1, and that both Sub1 and Spt5 copurify 
in the same complex, likely during early transcription elongation. Indeed, our data indicate 
that Sub1 influences Spt5–Rpb1 interaction. In addition, biochemical and molecular data 
show that Sub1 influences transcription elongation of constitutive and inducible genes and 
associates with coding regions in a transcription-dependent manner. Taken together, our re-
sults indicate that Sub1 associates with Spt5 and influences Spt5–Rpb1 complex levels and 
consequently transcription elongation rate.
INTRODUCTION
Transcription by RNA polymerase II (RNAPII) can be divided into 
the following steps: RNAPII recruitment to gene promoters and the 
assembly of the preinitiation complex (PIC) and promoter clear-
ance, initiation, elongation, and termination. For many years, the 
coordinated recruitment of the transcriptional machinery to form 
the PIC has been considered to be the principal step for the regula-
tion of transcription. However, recent data show that the elonga-
tion phase is also highly regulated in eukaryotic cells and strictly 
coordinated with other nuclear processes, such as remodeling, 
DNA repair, recombination, and replication. In fact, in addition to 
the basal elongation factors, a number of factors involved in mRNA 
processing, chromatin modification, remodeling, and mRNA export 
are also recruited during transcription elongation (reviewed in 
(Shilatifard et al., 2003; Saunders et al., 2006; Selth et al., 2010). In 
Saccharomyces cerevisiae, these factors include the basal elonga-
tion factors TFIIS and the Spt4/Spt5 complex, the chromatin as-
sembly factor Spt16/Pob3 (known as FACT in higher eukaryotes), 
and the polymerase-associated factor (PAF) complex (Shilatifard 
et al., 2003; Saunders et al., 2006; Selth et al., 2010). Spt5 (NusG in 
bacteria) is the only RNA polymerase–associated factor that is con-
served in all living organisms (Vassylyev et al., 2002; Korkhin et al., 
2009; Grohmann and Werner, 2011). It contains a conserved NGN 
domain that stimulates transcription elongation and RNAP proces-
sivity (Burova et al., 1995; Chen et al., 2009). In the case of Eukarya 
and Archaea, this domain binds to the RNAP and Spt4 to form the 
Spt4/5 elongation complex (Guo et al., 2008; Hirtreiter et al., 2010; 
Klein et al., 2011; Martinez-Rucobo et al., 2011).
Transcription elongation is regulated not only by elongation fac-
tors but also by the phosphorylation of the carboxy-terminal domain 
(CTD) of the largest subunit of RNAPII. Phosphorylation of the CTD 
by CTD-modifying enzymes occurs predominantly on the Ser-2 and 
Ser-5 residues (Sims et al., 2004; Saunders et al., 2006). The level of 
Ser-5 phosphorylation peaks early in the transcription cycle due to 
the action of Kin28 and remains constant or decreases as RNAPII 
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expression by real-time quantitative PCR (RT-qPCR), RNAPII associa-
tion with constitutive and regulated genes by chromatin immuno-
precipitation (ChIP), and levels of active elongation-competent 
polymerase by transcriptional run-on (TRO) assay.
The GLAM assay specifically detects defects in elongation and is 
used to measure the efficiency of gene-length–dependent mRNA 
accumulation (Morillo-Huesca et al., 2006). The wild-type (wt) and 
sub1Δ strains were transformed with three plasmids containing tran-
scription units of different lengths, with the same PHO5 coding se-
quences under control of the GAL1 promoter and variable 3′ un-
translated sequences (Figure 1A). The ratios of acid phosphatase 
activity for the long transcripts versus the short transcripts (GLAM 
ratios) were calculated for each strain (Figure 1C). We also analyzed 
the spt5-194 mutant, as a positive control for elongation defects, 
and the corresponding wt strain. As shown in Figure 1B (left), the 
GLAM ratio for spt5-194 was dramatically reduced compared with 
the wt ratio, consistent with its function as an elongation factor. 
Similar values have been reported for other elongation factor mu-
tants, such as spt4Δ, and for PAF1 complex mutants (Morillo-Huesca 
et al., 2006; Gaillard et al., 2009). Of interest, the GLAM ratio for 
sub1Δ cells was also significantly reduced (Figure 1C, left) but to a 
lesser extent than in spt5-194 cells (Figure 1B, left). The gene-
length–dependent defect observed with spt5-194 and sub1Δ cells 
was further confirmed by RT-PCR assays performed with cDNA gen-
erated from spt5-194, sub1Δ, and the two corresponding wt strains 
bearing the different transcription units or an empty plasmid as a 
mock control (Figure 1, B and C, right). Our results showed that 
PHO5 expression decreased in both spt5-194 and sub1Δ cells when 
expressed as long transcription units containing either the lacZ or 
LAC4 3′ untranslated sequences but was not affected when PHO5 
was transcribed from the short transcription unit.
Sub1 promotes transcription elongation and associates 
with coding regions
The IMD2 gene encodes a rate-limiting enzyme in the de novo syn-
thesis of GTP (IMP dehydrogenase 2), and its expression is increased 
by treatment with the GTP-depleting drugs mycophenolic acid 
(MPA) and 6-azauracil (6AU; Shaw and Reines, 2000; Escobar-
Henriques et al., 2001). Although their mechanism is not well under-
stood (Jenks et al., 2008; Kuehner and Brow, 2008), these com-
pounds have been widely used to identify proteins involved in 
transcription elongation (Shaw and Reines, 2000; Desmoucelles 
et al., 2002; Riles et al., 2004). In fact, mutations in several of the 
genes encoding components of the transcriptional elongation ma-
chinery confer sensitivity to 6AU in S. cerevisiae due to the resulting 
inability to induce IMD2 transcription (Shaw and Reines, 2000; Riles 
et al., 2004). IMD2 transcription is regulated by the selection of dif-
ferent start sites. Upstream starts sites lead to short, noncoding tran-
scripts that are prematurely terminated and degraded in noninduc-
ing conditions, whereas a downstream start is selected upon 
nucleotide limitation, leading to IMD2 induction (Jenks et al., 2008; 
Kuehner and Brow, 2008).
It has been proposed that Sub1 represses IMD2 gene expression 
upon binding to the promoter in noninduced conditions (Koyama 
et al., 2008), in which only upstream short, noncoding transcripts are 
synthesized and IMD2 is not transcribed. In fact, deletion of SUB1 
increases the expression of IMD2 in normal growth conditions, 
whereas its expression is avoided in wt cells (Koyama et al., 2008). 
However, Sub1 effects on IMD2 expression may be explained in part 
by a mechanism involving transcription start site selection (TSS), con-
sistent with recent data showing that SUB1 deletion alters TSS selec-
tion (N. Krogan, personal communication). Thus, in the absence of 
Rodriguez et al., 2000; Schroeder et al., 2000). In contrast, Ser-2 
phosphorylation is the predominant modification in the body and 
toward the 3′ end of the gene and occurs concurrently with produc-
tive elongation (Komarnitsky et al., 2000; Buratowski, 2009). Ctk1 is 
the principal kinase responsible for Ser-2 phosphorylation, which is 
important for the recruitment of the histone methyltransferase Set2 
and the association of the polyadenylation and termination factors 
with RNAPII (Cho et al., 2001; Ahn et al., 2004). In addition to Ctk1, 
the Bur1/Bur2 kinase complex phosphorylates Ser-2 when RNAPII is 
near the promoter and stimulates Ser-2 phosphorylation by Ctk1 
during elongation (Qiu et al., 2009). Bur1 also phosphorylates the 
histone modifier Rad6/Bre1 (Wood et al., 2005) and the carboxyl-
terminal domain of the elongation factor Spt5, which stimulates the 
recruitment of the PAF1 elongation complex (Liu et al., 2009; Zhou 
et al., 2009). In addition, we recently showed that the transcriptional 
coactivator Sub1 globally regulates RNAPII-CTD phosphorylation 
during the entire transcription cycle through the action of all CTD 
kinases (Garcia et al., 2010), suggesting that it might also have a role 
in transcription elongation.
Sub1 has been implicated in several steps of mRNA metabolism, 
including initiation, transcription termination, and 3′-end processing 
(Henry et al., 1996; Knaus et al., 1996; Calvo and Manley, 2001; He 
et al., 2003). It was originally described as a transcriptional stimula-
tory protein that is homologous to the human positive coactivator 
PC4 (Ge and Roeder, 1994; Kaiser et al., 1995; Malik et al., 1998). 
Sub1 genetically and physically interacts with TFIIB (Henry et al., 
1996; Knaus et al., 1996), and most recently it has been reported 
that Sub1 is a PIC component (Sikorski et al., 2011). In addition, 
Sub1 contributes to the activation of osmoresponse genes during 
osmotic shock (Rosonina et al., 2009) and to the regulation of IMD2 
gene expression (Koyama et al., 2008). Moreover, it has been sug-
gested that Sub1 might have a role in transcription elongation 
based on the following observations: 1) Sub1 function is linked to 
CTD elongation kinases (Calvo and Manley, 2005; Garcia et al., 
2010); 2) SUB1 genetically interacts with FCP1, which encodes the 
Ser-2 CTD phosphatase Fcp1 (Calvo and Manley, 2005); 3) cells lack-
ing Sub1 display decreased accumulation of Fcp1, altered RNAPII 
phosphorylation, and decreased cross-linking of RNAPII to tran-
scribed genes (Calvo and Manley, 2005).
Here we present evidence that Sub1 plays a role in transcription 
elongation. We show that SUB1 genetically interacts with SPT5. 
Sub1 regulates Spt5 phosphorylation by the CTD kinase Bur1, and 
both Sub1 and Spt5 copurify in the same complex, likely during 
early transcription elongation. Indeed, our data indicate that Sub1 
influences Spt5–Rpb1 levels. We also show that Sub1 promotes 
transcription elongation of constitutive and inducible genes and 
that it associates with coding regions in a transcription-dependent 
manner. Taken together, our results indicate that Sub1 associates 
with Spt5 and influences Spt5–Rpb1 complex levels and conse-
quently transcription elongation rates.
RESULTS
Sub1 influences the efficiency of transcription elongation 
of long transcripts
We previously presented evidence suggesting that Sub1 could indi-
rectly influence transcription elongation via its effects on the asso-
ciation of RNAPII with chromatin during active transcription and on 
the phosphorylation of the RNAPII CTD (Calvo and Manley, 2005; 
Garcia et al., 2010). Therefore we first investigated whether Sub1 
indeed is able to influence transcription elongation, using several 
different strategies: we studied elongation efficiency by the gene-
length–dependent mRNA accumulation (GLAM) assay, IMD2 gene 
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we cannot rule out that this effect on bur1 
cells can be gene specific because we did 
not analyze IMD2 expression levels in the 
bur1 and bur1sub1Δ cells. In any case, our 
data suggest that full expression of the 
IMD2 gene after 6AU induction may be in-
fluenced by Sub1 function, and in addition 
to its involvement in TSS selection, when 
bound to the promoter in noninduced con-
ditions and when short transcripts from the 
IMD2 promoter are being transcribed, Sub1 
might also have a role farther downstream 
during IMD2 elongation after induction.
To investigate further whether Sub1 par-
ticipates in transcription elongation, we ana-
lyzed the association of Sub1-hemagglutinin 
(HA) with the IMD2 and PMA1 promoters 
and coding regions in the presence or ab-
sence of 6AU. As shown in Figure 2B, and as 
previously reported, Sub1-HA associated 
with the PMA1 and IMD2 promoters under 
normal growth conditions (Calvo and 
Manley, 2005; Koyama et al., 2008). The as-
sociation of Sub1-HA with the IMD2 coding 
region was near the lower limit of detection 
in the absence of 6AU (Figure 2B, left), and 
it was almost undetectable in the 3′-end 
region. Conversely, Sub1-HA was found to 
be associated with the constitutively tran-
scribed PMA1 gene from the promoter to 
the 3′-end regions (Figure 2, B, right, and D; 
Calvo and Manley, 2005; Sikorski et al., 
2011). Curiously, we observed that after 
6AU treatment, Sub1-HA association with 
the IMD2 promoter increased (Figure 2B, 
left; note that the graphs are presented on a 
logarithmic scale), whereas its association with the PMA1 promoter 
decreased (Figure 2B, right). In addition, we detected an increase in 
the association of Sub1-HA with IMD2 coding and the 3′-end re-
gions of ∼4 and 6.5 times, respectively, above the background levels 
in the noninduced conditions (Figure 2B, left) and a decrease in the 
association with the PMA1 5′-coding regions (Figure 2B, right).
We also analyzed the association of TFIIB (Sua7) with chromatin 
as a negative control (Figure 2C) because TFIIB is a well-character-
ized PIC component with no role in transcription elongation and 
close genetic and functional connections with Sub1 (Knaus et al., 
1996; Wu et al., 1999; Rosonina et al., 2009). For this purpose, we 
used a TFIIB-MYC strain for ChIP assays. As expected, TFIIB only 
associates efficiently with the IMD2 promoter region regardless of 
6AU treatment, although a slight increase in TFIIB association above 
background was observed at the 3′-end after induction, possibly 
due to its role in gene looping (Singh and Hampsey, 2007). In the 
case of the PMA1 gene, both Sub1 and TFIIB associate with the 
promoter, but only Sub1 shows an association that is significantly 
above background with coding regions (Figure 2D). These results 
provide strong evidence that Sub1 plays a role in IMD2 transcription 
elongation under induction conditions and may also have a role dur-
ing transcription elongation of the constitutive PMA1 gene.
We next analyzed Sub1 association with the long transcription 
unit of the YLR454 gene (8 kb), which is expressed under the con-
trol of the GAL1 promoter (Mason and Struhl, 2005). The purpose 
of this experiment was to provide evidence that the signal over the 
Sub1 in noninduced conditions, transcription from the downstream 
start site may be preferred, resulting in constitutive IMD2 expression. 
This explains why sub1Δ cells are resistant to MPA or 6AU treatment 
in solid media (Koyama et al., 2008; Garcia et al., 2010). However, we 
observed that sub1Δ cells have reduced growth in liquid media con-
taining 6AU and that the SUB1 deletion conferred high sensitivity to 
6AU when combined with two bur1 mutations (Garcia et al., 2010). 
These data suggest that Sub1 could also have a role during tran-
scription elongation. Indeed, recently it was shown that Rpb1 muta-
tions in the trigger loop cause sensitivity or resistance to MPA, which 
correlates with a shift to upstream or downstream IMD2 start sites 
and with increased or reduced elongation rates, respectively (Kaplan 
et al., 2012).
Therefore we first decided to analyze IMD2 expression in wt and 
sub1Δ cells in the presence or absence of 6AU. As shown in Figure 
2A (left), IMD2 expression increased by more than 10-fold in sub1Δ 
cells compared with wt cells in normal growth conditions. When 
cells were treated with 6AU, IMD2 mRNA levels increased signifi-
cantly in wt cells as expected but did not further increase in sub1Δ 
cells (Figure 2A, left). This is more evident when we calculated the 
+6AU/−6AU ratios (Figure 2A, right). Then, this result indicates that 
Sub1 effect on IMD2 expression is epistatic to 6AU activation. In 
addition, the lack of further activation of IMD2 by 6AU in sub1Δ cells 
is in agreement with the fact that these cells are sensitive to 6AU 
when grown in liquid media and that the SUB1 deletion enhanced 
the 6AU sensitivity of bur1 mutants (Garcia et al., 2010). However, 
FIGURE 1: Deletion of SUB1 leads to altered transcription elongation efficiency of long 
transcripts. (A) Schematic representation of the three transcription units used in the GLAM 
assays. (B) The wt and spt5-194 strains were transformed with the plasmid bearing the three 
transcription units shown in A. GLAM ratios were calculated as the relative levels of acidic 
phosphatase activity expressed by the indicated transcription unit (GAL-PHO5 LacZ or 
GAL-PHO5 LAC4) with respect to the acid phosphatase activity from the shortest transcription 
unit (GAL-PHO5). Left, a representation of the GLAM ratios. Right, the RT-PCR results of PHO5 
expression from the three transcription units and from the mock strain bearing an empty 
plasmid. ADH1 was used as loading control. PCR products were run on an ethidium bromide–
stained gel. (C) GLAM ratios and RT-PCR results for the wt and sub1Δ strains.
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long as YLR454 are rarely found in S. cerevisiae. Nonetheless, this 
result provides further evidence that Sub1 associates with at least 
the coding regions of average size and even longer genes (e.g., 
PMA1) in S. cerevisiae and further supports the hypothesis that 
Sub1 may have a role during transcription elongation.
We also investigated whether Sub1 has a role in transcription 
elongation by analyzing Rpb1 occupancy from the promoter to 3′-
end regions of the IMD2 and PMA1 genes in both wt and sub1Δ 
cells in the presence or absence of 6AU. We (Calvo and Manley, 
2005; Garcia et al., 2010) and others (Rosonina et al., 2009; Sikorski 
et al., 2011) have already reported that there is decreased associa-
tion of RNAPII with the chromatin of constitutively transcribed genes 
genes is meaningful and not due to a decrease in the strong pro-
moter signal over distance as a consequence of the average chro-
matin shearing (∼300 base pairs). In addition, by analysis of the 
Sub1 association with a long gene, the coding region signal can be 
separated from a promoter signal due to any tandem-oriented 
downstream gene near the 3′-end region. As shown in Figure 2E, 
Sub1-HA associates with coding regions during galactose induc-
tion and disassociates after glucose-mediated transcriptional re-
pression. The Sub1 association with chromatin remains significant 
as far as 4 kb downstream from the promoter, whereas its associa-
tion with the most 3′-end is slightly above background. It is worth 
noting that most yeast genes are ∼1.5–2 kb long, and genes as 
FIGURE 2: Sub1 promotes transcription elongation, associates with coding regions, and influences Rpb1 association to 
chromatin during transcription elongation. (A) RT-qPCR analysis of the IMD2 gene. Total RNA was isolated from wt and 
sub1Δ cells grown in SC-URA with or without 50 μg/ml 6AU. cDNA synthesis was performed and coupled with qPCR. 
IMD2 expression values were normalized to the 18S rRNA values and graphed. The relative levels of the IMD2 mRNA in 
sub1Δ vs. wt cells are shown. (B) ChIP analysis of Sub1-HA was performed in the wt strain using an anti-HA antibody. 
Cross-linking to the IMD2 (left) and PMA1 (right) promoter and coding regions in the presence or absence of 100 μg/ml 
of 6AU was analyzed by qPCR. Quantifications of the results are shown in the graph, where the numbers on the y-axis 
represent the ratio of the values obtained from specific primer products to the negative control (intergenic region of 
chromosome VII) and normalized to the input controls. A schematic representation of the IMD2 and PMA1 genes is 
shown below the corresponding graph; the PCR primers pairs corresponding to the promoter and coding regions at the 
specified positions are indicated. In the case of the IMD2 gene, the upstream white box represents the promoter 
transcribed region leading to short, noncoding transcripts (Jenks et al., 2008). (C) ChIP assay to analyze the Sua7-MYC 
association with the IMD2 gene as in B. (D) ChIP analysis of the Sub1-HA and Sua7-MYC association with the PMA1 
gene. (E) Sub1-HA occupancy during galactose induction and after 4 min of glucose treatment. A schematic 
representation of the GAL1-YLR454 gene; the PCR primers pairs corresponding to the promoter and coding regions at 
the specified positions are indicated. (F) Rpb1 occupancy at the promoter and coding regions of the PMA1 gene was 
assayed by ChIP in wt and sub1Δ cells in the presence or absence of 100 μg/ml of 6AU with the 8WG16 antibody. 
Real-time qPCR quantifications were graphed as described. (G) Rpb1 occupancy at the promoter (left) and coding 
(middle) regions of the IMD2 gene assayed as in F. Right, the +6AU/−6AU ratio. Rpb1 cross-linking to promoter and 
coding regions was independently quantified in wt and sub1Δ cells, and the +6AU/−6AU ratio was then calculated and 
graphed.
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occupancy along the GAL1-YLR454 gene as previously described 
(Mason and Struhl, 2005) to study RNAPII processivity (Figure 3C). 
Surprisingly, deletion of SUB1 resulted in either no effect or a slight 
increase of Rpb1 association downstream of the promoter and along 
the gene. We then analyzed whether the decrease of Rpb1 density 
from promoter to 3′-end regions (Figure 3B) was due to the slowed 
progression of RNAPII across the gene. We analyzed the relative 
Rpb1 association to chromatin after repressing transcription of the 
GAL1-YLR454 gene with glucose for 4 min (Mason and Struhl, 2005; 
Quan and Hartzog, 2010). All regions examined in the sub1Δ mutant 
showed significantly higher RNAPII occupancy than in wt cells 
(Figure 3D). This result is similar to what was described for the 
spt5-242 mutation, which affects the elongation rate without affect-
ing processivity (Quan and Hartzog, 2010). These results support 
the hypothesis that elongation of RNAPII across the gene is im-
paired in sub1Δ, resulting in more RNAPII association within the 
body of the gene after the last wave of transcription.
ChIP assays measure the levels of polymerases associated with 
chromatin during active transcription (Mason and Struhl, 2005). 
However, ChIP does not specifically distinguish the active, elonga-
tion-competent form of the polymerase, for instance, from arrested 
or paused polymerase (Hirayoshi and Lis, 1999; Rodriguez-Gil et al., 
2010). However, the TRO assay enables measurement of the density 
of actively transcribing RNA polymerases by labeling nascent pre-
mRNA (Birse et al., 1998; Hirayoshi and Lis, 1999; Rodriguez-Gil 
et al., 2010). We therefore used TRO to study the distribution of 
transcriptionally competent polymerases along the GAL1-YLR454 
gene in wt and sub1Δ cells. We designed 300–base pair probes 
distributed along the gene (Figure 4A) and performed TRO. A rep-
resentative slot blot filter and quantification of three independent 
experiments are shown in Figure 4, B and C, respectively. We ob-
served that active RNAPII is significantly decreased in sub1Δ cells 
when compared with wt cells and that this decrease is stronger in 
the 5′ region of the YLR454 gene (Figure 4B). This result agrees with 
the ChIP experiments (Figure 3B). However, when we analyzed the 
relative levels of active RNAPII along the gene with respect to the 5′ 
region (ATG; Figure 4C), we observed a significant reduction of ac-
tive polymerase in sub1Δ cells. This result indicates that the higher 
occupancy of Rpb1 along the GAL1-YLR454 gene observed by ChIP 
in the absence of Sub1 (Figure 3D) corresponds to inactive, arrested 
polymerases that most likely cannot efficiently resume transcription. 
Taken together, the data presented here show that Sub1 influences 
transcription elongation.
Sub1 is genetically linked to the Spt4/Spt5 
elongation complex
We just showed that SUB1 deletion causes transcription elongation 
rate defects similar to those displayed by the spt5-242 mutant (Quan 
and Hartzog, 2010). In addition, our previous work showed a func-
tional connection between Sub1 and the CTD-elongation kinase 
Bur1 (Calvo and Manley, 2005; Garcia et al., 2010). We then decided 
to investigate whether Sub1 is genetically and functionally linked to 
the essential elongation factor Spt5, which is also phosphorylated 
by Bur1 (Liu et al., 2009; Zhou et al., 2009). Spt5 associates with 
Spt4, and the Spt4/5 complex is required for efficient elongation by 
RNAPII (Hartzog et al., 1998; Wada et al., 1998). We first performed 
genetic studies using two spt5 mutants—spt5-194 and spt5-242—
which impair RNAPII transcription elongation: spt5-194 grows slowly 
at 37°C and has very moderate sensitivity to 6AU, whereas spt5-242 
is cold sensitive and not sensitive to 6AU (Winston et al., 1984; 
Swanson et al., 1991; Swanson and Winston, 1992; Hartzog et al., 
1996, 1998). In contrast, sub1Δ cells grow normally and are not 
in the promoter and coding regions in cells lacking Sub1. Here we 
extended our study to the IMD2 gene, regulated by guanine nucle-
otide levels. In agreement with our previous data, we observed a 
reduction in the association of Rpb1 with the PMA1 gene in sub1Δ 
cells compared with wt cells when grown under normal conditions, 
and this reduction was further enhanced with 6AU treatment (Figure 
2F). Rpb1 association with the coding and 3′-end regions of the 
IMD2 gene was undetectable in wt cells, as expected, in accordance 
with IMD2 repression in normal growth conditions (Figure 2G, left). 
However, after 6AU treatment, Rpb1 was efficiently recruited to 
IMD2 coding regions. The opposite was observed when we ana-
lyzed Rpb1 association with the IMD2 gene in sub1Δ cells (Figure 
2G, middle). That is, an increase of Rpb1 association with the coding 
regions of IMD2 in noninduced conditions and a reduction after in-
duction was observed. However, this reduction is not further en-
hanced at the 3′-end regions. In any case, the Rpb1 ChIP data com-
pletely paralleled the IMD2 expression levels (Figure 2A) because 
there was a decrease in the association of Rpb1 with the IMD2 gene 
along with a reduction of IMD2 mRNA after 6AU treatment in sub1Δ 
cells compared with wt cells. In fact, when we calculated the 
+6AU/−6AU ratio of Rpb1 association (Figure 2G, right), we clearly 
observed a dramatic reduction along the entire gene in sub1Δ cells 
compared with wt cells.
In summary, our results indicate that the reduction in nucleotide 
levels after 6AU treatment causes transcription elongation to be-
come more dependent on the presence of Sub1. This is supported 
by the fact that Sub1-HA associates with the IMD2 coding regions 
during transcription elongation and the fact that Rpb1 association 
to chromatin is reduced in sub1Δ cells during transcription elonga-
tion after induction. Taken together, our data support the hypothesis 
that Sub1 influences transcription elongation, although they do not 
definitively indicate that Sub1 plays a direct role in that process. In 
fact, as SUB1 deletion affects IMD2 expression, and thus nucleotide 
levels could be lower in sub1Δ cells, suggesting the possibility that 
the effect of Sub1 on transcription elongation could be indirect 
through IMD2.
Sub1 influences RNAPII transcription elongation rate
Mason and Struhl (2005) developed an assay to measure two dis-
tinct aspects of the elongation process: the rate of transcription and 
the processivity of RNAPII. They showed that for RNAPII processiv-
ity, mutations on the well-known transcription elongation factors fall 
into three categories: 1) mutations that reduce RNAPII processivity; 
2) mutations that reduce processivity only in the presence of 6AU; 
and 3) mutations that do not affect processivity. Transcription factors 
with roles in transcription elongation have subsequently been de-
scribed (Chanarat et al., 2011; Gonzalez-Aguilera et al., 2011; Kruk 
et al., 2011). For example, the Ccr4–Not complex belongs to a new 
category because mutations on the subunits of Crc4–Not cause in-
creased RNAPII processivity and reduced elongation rate (Kruk 
et al., 2011). Furthermore, a mutation on the Spt5 elongation factor 
(spt5-242) affects the transcription elongation rate without affecting 
processivity (Quan and Hartzog, 2010). We used the same assay as 
Mason and Struhl (2005) to measure the level of RNAPII association 
with various positions within the 8 kb of the GAL1-YLR454 fusion 
gene, inducible by galactose in wt and sub1Δ cells (Figure 3A). Our 
data showed that, as in the case of the PMA1 gene, RNAPII levels 
are decreased from the promoter to the 3′ end in sub1Δ cells when 
compared with wt cells (Figure 3B). However, the decrease of Rpb1 
density in the 3′-end regions is significantly less pronounced than at 
the promoter. This finding suggests that the absence of Sub1 does 
not cause a processivity defect. Next, we analyzed the relative Rpb1 
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immunoprecipitated (IPed) from wt and sub1Δ whole-cell extracts 
prepared from cells expressing HA-Bur1 via the HA epitope tag. IP 
products were subjected to an in vitro IP kinase assay, with or without 
the addition of ATP (Garcia et al., 2010), using a recombinant hexahis-
tidine (6HIS)-Spt5 protein (rSpt5; Liu et al., 2009) as the substrate. 
Immunoblotting with the phosphospecific anti–Spt5-P antibody (Liu 
et al., 2009; Figure 6A, top) and an antibody that recognizes the N-
terminal region of Spt5 (Figure 6A, bottom) showed that Bur1 activity 
was higher in sub1Δ than in wt cells. As a control, equivalent IP of 
Bur1-HA was confirmed by Western blot using an anti-HA antibody 
(Figure 6A, right). To extend these results, we performed an in vitro 
kinase assay as a positive control for Bur1-HA kinase activity. We 
tested the ability of Bur1-HA IPed from wt and sub1Δ strains and 
Bur1-23-HA (with reduced kinase activity) IPed from bur1-23 cells 
(Keogh et al., 2003) to phosphorylate the glutathione S-transferase 
(GST)-CTD fusion protein on Ser-5. As shown in Figure 6B, Bur1-HA 
IPed from wt and sub1Δ cell extracts was fully active because it effi-
ciently phosphorylated GST-CTD as determined by immunoblotting. 
In addition, Bur1 activity was greater in sub1Δ cell extracts than in wt 
cells, as previously reported (Garcia et al., 2010), and there was also a 
significant reduction in the phosphorylation of GST-CTD in the bur1-
23 cell extracts, which is in agreement with previous work (Keogh 
sensitive to 6AU in solid media (Figure 5, A and C; Garcia et al., 
2010). However, spt5-194 sub1Δ and spt5-242 sub1Δ double mu-
tants both have increased temperature-sensitive growth defects at 
37 and 28°C, respectively, and are highly sensitive to 6AU (Figure 
5A). Overexpression of SUB1 suppresses the growth defects of the 
spt5-194 mutant (Figure 5B), although not entirely. In fact, overex-
pression of SUB1 in wt cells causes a slight growth defect, as already 
reported (Calvo and Manley, 2001). Subsequently, we also tested 
whether Sub1 is genetically linked to Spt4. As shown in Figure 5C, 
combining the SUB1 deletion with the temperature-sensitive mu-
tant spt4Δ results in a very strong synthetic growth defect and ex-
treme 6AU sensitivity. Therefore Sub1 is genetically linked to both 
Spt4 and Spt5, suggesting that Sub1 might be functionally linked to 
the Spt4/Spt5 elongation complex.
Deletion of SUB1 enhances Spt5 phosphorylation 
by Bur1 but not its recruitment to chromatin
We next tested whether Sub1 affects Spt5 phosphorylation by Bur1, 
because it has been shown that Bur1 phosphorylates the carboxy-
terminal domain of Spt5, thereby stimulating the recruitment of PAF 
(Liu et al., 2009) and histone-modifying proteins (Zhou et al., 2009) to 
the elongation complex. HA-Bur1–containing complexes were 
FIGURE 3: Deletion of SUB1 leads to transcription elongation rate defects. (A) A schematic representation of the 
GAL1-YLR454 gene. PCR primer pairs corresponding to the promoter and coding region at the specified positions are 
indicated. (B) Total Rpb1 occupancy at the promoter and coding regions of the GAL1-YLR454 gene was assayed by 
ChIP, using 8WG16 antibody in wt and sub1Δ galactose-induced cells. Quantifications of qPCR were graphed as 
described in Figure 2. (C) Measurement of RNAPII processivity. Relative Rpb1 occupancy at the GAL1-YLR454 gene in 
wt and sub1Δ cells at the indicated positions after inducing conditions. The qPCR values were first normalized to the 
values at the promoter (P) and then with respect to the wt cells values, taken as 1, for each probe as previously 
described (Mason and Struhl, 2005). (D) Measurement of the elongation rate as described in Mason and Struhl (2005). 
Relative Rpb1 occupancy of galactose-induced cells in wt and sub1Δ cells along the GAL1-YLR454 gene after 4 min of 
glucose treatment (glucose/galactose ratio). Increased association of RNAPII with the coding region in the sub1Δ cells 
results in reduced polymerase dissociation after the last wave of transcription, leading to an elongation rate defect.
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of the tested genes (unpublished data). 
Taken together, our data support the idea 
that Sub1 associates with the transcription 
complex and modulates the phosphoryla-
tion of the CTDs of Rpb1 (Garcia et al., 2010) 
and Spt5.
The exact mechanisms by which Sub1 
influences Bur1 kinase activity remain un-
known. One possibility is that the effects of 
Sub1 on Bur1 activity may be indirect, 
through Kin28, because SUB1 deletion in-
creases Kin28 recruitment and activity 
(Garcia et al., 2010) and Kin28 promotes 
Bur1 kinase recruitment and Spt5 phospho-
rylation (Qiu et al., 2009, 2012). Another 
possibility is through replication protein RPA, 
because both Sub1 and Bur1 have been ge-
netically and functionally linked to RPA. The 
Bur1/2 complex interacts with RPA and 
maintains genome stability during replica-
tion stress (Clausing et al., 2010). In contrast, 
the Rfa1 subunit of RPA seems to compete 
with Sub1 for chromatin binding to promoter 
regions (Sikorski et al., 2011). Indeed, Rfa1 is 
able to associate with promoter regions dur-
ing active transcription only in the absence 
of Sub1. The increased Rfa1 association in 
sub1Δ cells could then enhance Bur1 recruit-
ment (because they both directly interact) 
and therefore kinase activity. However, Bur1 
recruitment is not altered when Sub1 is lack-
ing (Garcia et al., 2010). Nevertheless, we 
cannot rule out that Sub1 may indirectly in-
fluence Bur1 kinase activity during transcrip-
tion elongation through Rfa1.
SUB1 deletion suppresses the splicing defect 
of a spt5-194 mutation
It has been shown that the transcription elongation rate influences 
splicing (de la Mata et al., 2003; Howe et al., 2003; Shukla and 
Oberdoerffer, 2012). Thus RNAPII mutants that slow transcription or 
cells treated with MPA and 6AU display increased exon inclusion 
(Howe et al., 2003). Because Sub1 influences the transcription elon-
gation rate, we decided to test whether SUB1 deletion also affects 
splicing.
Spt5 has been implicated in pre-mRNA processing because un-
spliced pre-mRNAs accumulate in spt5 mutants (Lindstrom et al., 
2003; Xiao et al., 2005). Therefore we analyzed splicing of the RPL26 
mRNA in the wt, sub1Δ, spt5-194, and spt5-194 sub1Δ strains. We 
isolated RNA from all four strains and performed RT-PCR to analyze 
the levels of the unspliced and mature RPL26A mRNA (Figure 6E; 
Lindstrom et al., 2003). We also analyzed the expression of PYK1, 
which does not contain introns. As shown in Figure 6E, the levels of 
mature and unspliced RPL26 pre-mRNA were similar in wt and 
sub1Δ cells. However, there was a large increase in the level of un-
spliced RPL26 pre-mRNA in the spt5-194 mutant, which is consis-
tent with previous work (Lindstrom et al., 2003). Of interest, when 
the SUB1 deletion was combined with the spt5-194 mutation, there 
was a significant reduction in the accumulation of unspliced RPL26. 
This result is consistent with a reduction of the transcription elonga-
tion rate in sub1Δ cells (Figure 3) and in agreement with the fact that 
elongation rates influences splicing (de la Mata et al., 2003; Howe 
et al., 2003). Taken together, these results show that Sub1 negatively 
influences Bur1 kinase activity toward the CTDs of both Spt5 and 
RNAPII (Figure 6, A and B; Garcia et al., 2010).
In light of the forgoing results, we next tested the extent of Bur1-
HA–specific kinase activity on the CTD of Spt5 in our assays using 
extracts from wt and sub1Δ strains expressing another kinase, such 
as Ctk1-HA (Garcia et al., 2010). In addition, we also tested the 
activity of the Bur1-23-HA mutant kinase with rSpt5. As shown in 
Figure 6C, only wild-type Bur1-HA (from wt and sub1Δ cell extracts) 
was able to phosphorylate the Spt5 CTD efficiently, which is consis-
tent with previous work (Zhou et al., 2009), and Spt5 phosphoryla-
tion was greater in the absence of Sub1.
We next determined whether Sub1 also affects Spt5 recruitment 
to gene promoters. Genome-wide occupancy profiles for yeast tran-
scription factors showed that elongation factors are recruited to 
the transcriptional machinery during a 5′ transition that occurs 
∼150 nucleotides downstream of the transcription start site (Mayer 
et al., 2010). We therefore analyzed the recruitment of Spt5 to the 5′ 
coding region of several constitutively transcribed genes (ADH1, 
PYK1, PMA1, and PDR5) between +150 to +400 nucleotides down-
stream of the transcription start site in the presence or absence of 
Sub1. For this purpose, we performed ChIP coupled with qPCR us-
ing wt and sub1Δ cells expressing Spt5-FLAG. As shown in Figure 
6D, the SUB1 deletion did not affect the association of Spt5 with the 
5′ coding region of the genes tested. We obtained the same result 
when we analyzed the association of Spt5 to the middle and 3′-end 
FIGURE 4: Active elongation-competent RNAPII is decreased in sub1Δ cells. (A) Diagram of 
the GAL1-YLR454 gene. Locations of the probes used in the TRO analysis are indicated. (B) TRO 
of wt and sub1Δ cells growing in galactose-containing medium. (C) Quantitation of blot 
hybridizations. Hybridization signals were quantitated by PhosphorImager analysis. The bacteria 
DNA background signal (C-) was subtracted from each probe, and, after normalization for 18S 
rRNA signal, the results were normalized to the ATG probe, which was fixed at 1.
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lanes 2 and 3, respectively). We immunoblotted the same mem-
brane with anti-FLAG antibody and only a fraction of Spt5-FLAG 
coIPed with Sub1-HA, as shown in Figure 7B (middle, lane 3). Then, 
It is possible that Sub1 associates with Spt5 in a transient manner. 
Consistent with this hypothesis, when we analyzed the association 
of Spt5-FLAG and Sub1-HA with the chromatin of several actively 
transcribed genes (PYK1 in Figure 7C and ADH1, PGK1, PMA1 and 
YEF3 in Supplemental Figure S1) we observed an increase in the 
association of Sub1-HA with the promoter regions, which rapidly 
declined downstream of the promoters but was maintained at a 
lower level throughout the 3′ end of the genes (Figure 7C; Nedea 
et al., 2003; Rosonina et al., 2009; Sikorski et al., 2011). In contrast, 
the association of Spt5-FLAG with the middle and 3′ regions of the 
open reading frames increased (Figure 7C and Supplemental 
Figure S1; see Mayer et al., 2010). Thus there is a small region, 
∼150–400 nucleotides downstream of the transcription start site 
(Figure 7C), where Spt5 and Sub1 might directly or indirectly inter-
act as part of the same complex during early elongation. Alterna-
tively, Sub1 might be less efficiently detected by ChIP in coding 
regions due to conformational changes occurring in the elongation 
apparatus that weaken the ability of Sub1 to bind to DNA but per-
mit interaction with the Spt4/Spt5 complex (see Discussion).
Deletion of SUB1 affects Spt5–Rpb1 interaction
Several lines of evidence suggested that Spt4/5 association with 
Rpb1 could be altered in sub1Δ. First, there is genetic interaction of 
et al., 2003). Similarly, N. Krogan and colleagues (personal commu-
nication) observed that slow RNAPII mutations or SUB1 deletion 
enhance splicing.
Sub1 and Spt5 copurify early during transcription 
elongation
Lindstrom et al. (2003) affinity purified Spt5-FLAG from yeast ex-
tracts and used mass spectrometry to identify a large number of 
proteins involved in transcription and pre-mRNA processing, in-
cluding Sub1. Nevertheless, the copurification of these two pro-
teins was not further confirmed. Therefore we performed a tandem 
affinity purification (TAP) assay to investigate whether Spt5 copuri-
fied with Sub1-TAP and subsequently confirmed our results by coIP. 
We first purified Sub1-TAP from yeast extracts (Rodriguez-Navarro 
et al., 2004), and we used an isogenic strain lacking the TAP tag 
(mock) as a control for nonspecific purification. Purified samples 
from both strains (Sub1-TAP and mock) were analyzed with a poly-
clonal anti-Spt5 antibody (Figure 7A). In accordance with previous 
work (Lindstrom et al., 2003), Spt5 associated with Sub1-TAP, indi-
cating that Sub1 and Spt5 might be part of the same complex. We 
also confirmed the copurification by IP experiments. We performed 
an anti-HA IP assay using whole-cell extracts from the Sub1-HA and 
the double-tagged Sub1-HA/Spt5-FLAG strains. We used the Spt5-
FLAG strain as a negative control for the anti-HA IP. As expected, 
Sub1 was efficiently IPed from the Sub1-HA and Sub1-HA/Spt5-
FLAG cell extracts (anti-HA immunodetection in Figure 7B, bottom, 
FIGURE 5: Sub1 is genetically linked to Spt5. Genetic interaction between SUB1, SPT5, and SPT4. (A) SUB1 deletion 
enhances the growth defects of spt5-194 and spt5-242 and causes 6AU sensitivity to them, and (B) overexpression of 
SUB1 suppresses spt5-194 growth phenotypes. To overexpress SUB1, its open reading frame was cloned under the 
control of the ADH1 promoter (ADH1SUB1). (C) SUB1 deletion enhances the growth thermosensitivity and 6AU 
sensitivity of spt4Δ mutant. Yeast strains with the indicated genotypes were spotted onto SC-URA and SC-URA media 
with 75, 50, or 25 μg/ml of 6AU and grown at 28 or 37°C for 2–3 d.
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FIGURE 6: Deletion of SUB1 enhances Spt5 phosphorylation by Bur1 but not its recruitment to the 5′ regions of genes. 
(A) In vitro kinase assay. WCEs were prepared from wt and sub1Δ strains expressing HA-tagged Bur1. The HA-tagged 
kinase complexes were IPed with 12CA5-protein A beads, and kinase activity was assayed using recombinant 6HIS-Spt5 
as substrate. SDS–PAGE and immunoblot analysis were performed to analyze Spt5 phosphorylation using the following 
antibodies: anti-P Spt5 (Liu et al., 2009), anti-Spt5, 12CA5 (anti-HA for Bur1-HA), and anti-PGK (for total protein level 
control). (B) WCEs were prepared from the Bur1-HA (wt and bur1-23 mutant) and Bur1-HA sub1Δ strains. In vitro kinase 
assays were conducted as described but using recombinant GST-CTD as substrate, and CTD Ser-5 phosphorylation was 
analyzed with the CTD4H8 (anti-CTD Ser5P) and 8WG16 (anti-CTD) antibodies. (C) WCEs were prepared from the wt 
and sub1Δ strains expressing HA-tagged Bur1 and Ctk1 and from bur1-23-HA mutant cells. In vitro kinase assays were 
performed to analyze Spt5 phosphorylation as described. (D) ChIP analyses were performed in the wt and sub1Δ strains 
expressing Spt5-FLAG. Spt5 binding to the 5′ region (the nucleotide position relative to the start codon is shown 
between brackets) of four constitutively expressed genes—ADH1, PYK1, PMA1, and PDR5—was examined by qPCR, 
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mutation causes elongation rate defects 
(Quan and Hartzog, 2010). Second, the 
NGN domain is required to interact with 
Rpb1 (Klein et al., 2011; Martinez-Rucobo 
et al., 2011) and overexpression of Sub1 
partially suppresses spt5-194 growth de-
fects. Third, the levels of active elongating 
polymerase are reduced in sub1Δ cells (Fig-
ure 4, B and C). Therefore we decided to 
investigate the interaction of Spt5 with 
Rpb1 in wt, sub1Δ, spt5-194, and spt5-194 
sub1Δ cells expressing Spt5-FLAG proteins. 
We IPed Spt5-FLAG from whole-cell ex-
tracts and analyzed the Rpb1 levels by 
Western blot analysis. As shown in Figure 
8A (inputs), the levels of Spt5 protein were 
unaffected in sub1Δ and spt5-194 cells 
when compared with wt cells but were 
slightly decreased in spt5-194 sub1Δ dou-
ble-mutant cells. This was not due to an ef-
fect of SUB1 deletion on SPT5 transcription, 
as revealed by the RT-PCR experiments 
(Figure 8B), but it may be an indication that 
Spt5 is more unstable in the double-mutant 
cells. When we analyzed the Spt5-FLAG IPs, 
we observed less Rpb1–Spt5 complex in 
sub1Δ and spt5-194 cells. Furthermore, this 
defect is significantly enhanced in the case 
of the spt5-194 sub1Δ double mutant, in 
which levels of the Rpb1–Spt5 complex 
were greatly reduced. To corroborate this 
result, we next IPed Rpb1 and analyzed the 
levels of coIPed Spt5-FLAG (Figure 8C). 
Similar levels of Rpb1 were IPed from 
wt, sub1Δ, spt5-194, and spt5-194sub1Δ 
strains. However, slightly less Spt5 associ-
ated with Rpb1 in sub1Δ compared with wt 
cells, and in the case of spt5-194 cells, the 
amount of Spt5 coIPed with Rbp1 was sig-
nificantly reduced. Moreover, this reduction 
was extraordinarily enhanced in the spt5-
194sub1Δ cells, in which Spt5 was almost 
undetectable.
Thus our results suggest that Sub1 
might help to maintain appropriate levels 
of Spt5 protein levels, directly or indirectly 
increasing its stability, and with special 
significance in the spt5-194 background. 
This is consistent with the essential nature 
of Spt5, with the requirement of a func-
tional NGN domain for the Spt5–Rpb1 interaction, and with the 
fact that overexpression of SUB1 suppresses spt5-194 growth de-
fects. Taken together, our data indicate that Sub1 influences the 
sub1Δ with spt4Δ, and with spt5-194 and spt5-242 mutations 
located in the NGN domain (Figure 5). The spt5-194 mutation 
disrupts Spt4–Spt5 interaction (Guo et al., 2008), and spt5-242 
FIGURE 7: Sub1 and Spt5 copurify during early transcription elongation. (A) Spt5 copurifies 
with Sub1-TAP. Tandem affinity purification was performed with a yeast strain expressing 
Sub1-TAP, and purified extracts were analyzed by Western blot using a polyclonal anti-Spt5 
antibody. An isogenic strain lacking the TAP tag was used as a control for nonspecific 
purification (mock). (B) Spt5-FLAG coimmunoprecipitates with Sub1-HA. WCEs were prepared 
from the strains Spt5-FLAG, Sub1-HA, and Sub1-HA/Spt5-FLAG, and anti-HA IPs were carried 
out. After extensive washing, inputs and IPs were analyzed by Western blotting. The upper and 
middle membranes were immunoblotted with anti-FLAG and the lower membrane with anti-HA. 
(C) ChIP analysis of Spt5 and Sub1 was conducted in the double-tagged Spt5-FLAG/Sub1-HA 
strain using anti-FLAG and anti-HA antibodies, respectively. Spt5-FLAG and Sub1-HA cross-
linking to the promoter, coding, and 3′ regions of the PYK1 gene was analyzed by qPCR, and 
the quantifications of the results are graphed as described in Figure 2. A schematic 
representation of the PYK1 gene is shown; the numbers indicate the nucleotide position relative 
to the start codon (+1), and the bars above the genes represent the PCR products analyzed by 
ChIP.
and quantifications were graphed (see Materials and Methods). The numbers on the y-axis represent the association of 
Spt5 with the 5′ regions of genes in sub1Δ cells relative to wt cells, in which cross-linking is considered 1. (E) RT-PCR 
analysis of the spliced and unspliced forms of the RPL26 gene. RNA was prepared from wt, sub1Δ, spt5-194, and 
spt5-194sub1Δ cells. Unspliced pre-mRNAs were specifically amplified using one primer from intron sequences and 
another from the second exon as previously described (Lindstrom et al., 2003). Another pair of primers was used to 
amplify the spliced RPL26 mRNA. As a loading control, PYK1, which does not contain introns, was also analyzed by 
RT-PCR. All PCRs were performed using 32P-dCTP, and the PCR products were run on an 8% polyacrylamide gel.
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cannot conclude from this assay alone whether a factor is involved 
directly in elongation, since mutations in factors involved in pre-
mRNA processing also show reduced GLAM ratios (Morillo-Huesca 
et al., 2006; Gaillard et al., 2009). In addition, ChIP analysis showed 
that in the sub1Δ mutant RNAPII association to chromatin was re-
duced, although measurement of in vivo processivity showed that 
the relative RNAPII association with chromatin is not altered or very 
slightly increased in sub1Δ cells. On the other hand, we observed 
a higher density of RNAPII after the last wave of transcription by 
ChIP in the absence of Sub1, indicating an elongation rate defect, 
which results in a decrease of active, competent elongating poly-
merase measured by TRO. Thus it is possible that the polymerase 
recruited to the promoter in sub1Δ cells is slower than in wild-type 
cells or does not efficiently resume transcription after transient 
stalling or arrest. Moreover, the role of Sub1 in the transcription 
elongation rate is further supported by data demonstrating that 
SUB1 deletion suppresses spt5-194 splicing defects, which is con-
sistent with the fact that elongation rates influence the splicing and 
selection of alternative splice sites (de la Mata et al., 2003; Howe 
et al., 2003).
The elongation rate defect has been also described for an Rpb2 
mutation (Mason and Struhl, 2005), for Ccr4-Not elongation com-
plex mutants (Kruk et al., 2011), and for the spt5-242 mutation 
(Quan and Hartzog, 2010). Therefore, given that the Spt5/Spt4 
complex affects RNAPII processivity and elongation rate (Mason 
interaction of Spt5 with Rpb1, consistent with all our demonstra-
tion that Sub1 influences transcription elongation.
DISCUSSION
Over the past several years, there has been an extraordinary increase 
in the number of proteins known to influence transcription elonga-
tion (Selth et al., 2010). Many of these proteins do not directly affect 
transcription elongation (Mason and Struhl, 2005), although they 
possess some of the criteria used to define them as elongation fac-
tors. These criteria include the ability to travel with elongating 
RNAPII and associate in vivo with coding regions in a transcription-
dependent manner (e.g., Krogan et al., 2002; Pokholok et al., 2002; 
Mason and Struhl, 2003; Kruk et al., 2011). One important character-
istic of a transcription elongation defect is the reduced association of 
RNAPII with transcribed regions from 5′ to 3′ ends, which may be a 
consequence of a defect in the elongation rate, processivity, or both 
(Mason and Struhl, 2005; Quan and Hartzog, 2010; Chanarat et al., 
2011; Kruk et al., 2011). Here we provided new insight into this pro-
cess by showing that Sub1, a PIC component, associates with the 
Spt5 elongation factor and influences transcription elongation rate.
Sub1 affects transcription elongation efficiency 
and elongation rate
We presented data showing a reduced elongation efficiency of 
long transcripts in sub1Δ cells by the GLAM assay. However, we 
FIGURE 8: Deletion of SUB1 negatively affects the Spt5-Rpb1 interaction. (A) CoIP of Spt5-Rpb1. WCEs of wt, sub1Δ, 
spt5-194, and spt5-194sub1Δ expressing the corresponding Spt5-FLAG and Spt5-194-FLAG proteins were used to 
perform anti-FLAG IPs. Western blots of the inputs and IPs were analyzed with anti-Rpb1 (top), anti-FLAG (middle), and 
anti-PGK (bottom). The CoIP was performed at least three times, and a representative experiment is shown. (B) RT-PCR 
analysis of the SPT5 gene. 18S rRNA was used as loading control. PCR products were run on an ethidium bromide–
stained gel. (C) CoIP of Spt5-Rpb1 as in A, but the IPs were performed with anti-Rpb1 (8WG16). Western blots of the 
inputs and IPs were also analyzed using the same antibodies as in A.
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detected in the PIC complexes; Liu et al., 2004; Garcia et al., 
2010), thus blocking Bur1 kinase activity and Spt5 recruitment and 
phosphorylation as well.
Our results are consistent with recently proposed models for 
Sub1 function in which Sub1 is recruited to promoters and helps to 
maintain the PIC in a stable but inactive conformation, possibly by 
helping TFIIE (Sikorski et al., 2011) and/or inhibiting Kin28 recruit-
ment and activity (Garcia et al., 2010), required to phosphorylate 
RNAPII-CTD on Ser-5 and to recruit capping enzymes (Komarnitsky 
et al., 2000; Buratowski, 2009). During transcription initiation, the 
phosphorylation of Sub1 would reduce its DNA-binding capacity 
(Ge et al., 1994; Henry et al., 1996; Jonker et al., 2006), alleviate ki-
nase inhibitory effects, and facilitate promoter clearance (Henry 
et al., 1996; Knaus et al., 1996; Sikorski et al., 2011) and capping 
enzymes recruitment (Garcia et al., 2010). During the initiation–
elongation transition, initiation factors are exchanged by elongation 
factors (Pokholok et al., 2002) and Spt4/Spt5 complex is recruited, 
binding the polymerase (e.g., Martinez-Rucobo et al., 2011) and the 
capping complex (Pei and Shuman, 2002). Thereafter, Bur1 phos-
phorylates Spt5 and RNAPII-CTDSer5P on Ser-2 to promote exten-
sive phosphorylation by Ctk1 farther downstream in coding and 
3′-end regions (Qiu et al., 2009), the capping complex is released, 
and productive transcription elongation is triggered (reviewed 
by Buratowski, 2009). In that context, our data indicate that Sub1 
joins the early elongation complex containing Spt4/Spt5 and influ-
ences transcription elongation, most likely by stabilizing Spt5–Rpb1 
association with DNA. This could help to decrease the time that 
this complex is paused immediately after the initiation–elongation 
transition and positively influences the transcription elongation 
rate. Moreover, extensive and specific phosphorylation events tar-
geting RNAPII (e.g., Buratowski, 2009), Spt5 (Liu et al., 2009; Zhou 
et al., 2009), and Sub1 (Ge et al., 1994; Henry et al., 1996; Jonker 
et al., 2006) could take place simultaneously and ultimately regu-
late the initiation–elongation transition and therefore transcription 
elongation.
Sub1 associates predominantly with promoters 
as a PIC component but also with coding regions 
as an elongation factor
If Sub1 associates with the Spt5 elongation factor and has a role 
during transcription elongation, why is Sub1 found associated pre-
dominantly with the promoter and 5′ coding regions? One possibil-
ity is that conformational changes occur in the elongation apparatus 
that may weaken the ability of Sub1 to bind to DNA or may interfere 
with detection by ChIP in the middle and 3′ ends of genes. It has 
been proposed that Sub1 competes with the more abundant sin-
gle-strand DNA (ssDNA)–binding protein Rfa1, which participates in 
transcription elongation and was purified with Sub1 in the PIC 
(Sikorski et al., 2011). In fact, Rfa1 associates with promoters in the 
absence of Sub1, whereas its association with coding regions is 
Sub1 independent. Because the in vitro ability of phospho-Sub1/
PC4 to bind to DNA is reduced, thus allowing it to escape from 
promoters (Ge et al., 1994; Henry et al., 1996; Jonker et al., 2006), 
it is possible that phosphorylated Sub1 will be less strongly associ-
ated with coding regions where Rfa1 ssDNA-binding affinity is in-
creased (Sikorski et al., 2011). Alternatively, in coding regions these 
two proteins could be bound to DNA in a noncompetitive manner. 
In fact, a SUB1 and RFA1 genetic interaction suggests some coop-
erative function (Sikorski et al., 2011), and both have been geneti-
cally and functionally linked to Bur1 function (Clausing et al., 2010; 
Garcia et al., 2010). Another possibility is that the majority of Sub1 
is associated with promoter regions, and only a small pool of Sub1 
and Struhl, 2005; Quan and Hartzog, 2010) and Sub1 appears to 
influence levels of an Rpb1–Spt5 complex, this provides an explana-
tion for the defects in the polymerase elongation rates observed in 
sub1Δ cells during transcription elongation. However, we cannot 
rule out that the Sub1 role in elongation may also derive from a 
promoter role and/or from a function in gene looping due to its 
close functional link with TFIIB (Knaus et al., 1996; Wu et al., 1999; 
Rosonina et al., 2009). Although different from TFIIB, Sub1 associ-
ates not only with promoters, but also with coding regions.
Sub1 is functionally linked to the elongation factor Spt5
Spt5 is present in the elongation complex but is not detected in 
the PIC. It is recruited to the transcriptional machinery during the 
initiation–elongation transition (Mayer et al., 2010), and structural 
studies recently showed that the conserved Spt5 NGN domain 
locks the nucleic acids in the polymerase cleft and maintains the 
transcription bubble (Martinez-Rucobo et al., 2011). It was recently 
reported that Sub1 is a PIC component that localizes at the pro-
moter, where DNA must be unwound for transcription (Sikorski 
et al., 2011), and we showed that it remains associated with cod-
ing regions during active transcription. Because Spt5 and Sub1 
bind to open transcription bubbles (Klein et al., 2011; Martinez-
Rucobo et al., 2011; Sikorski et al., 2011) and are associated with 
chromatin during early transcription elongation, and sub1Δ cells 
display reduced levels of RNAPII occupancy in coding regions, it 
is possible that Sub1 could redundantly help Spt5 associate with 
RNAPII during the initiation–elongation transition and positively 
promote transcription elongation. In agreement with this, Spt5 
levels associated with Rpb1 are slightly reduced in sub1Δ cells, 
and this defect is significantly enhanced in the double mutant 
spt5-194 sub1Δ. This is consistent with the fact that the spt5-194 
mutation is located in the NGN domain of Spt5, which directly 
binds to Rpb1 and Spt4 (Klein et al., 2011; Martinez-Rucobo et al., 
2011). In addition, the spt5-194 mutation interrupts Spt4–Spt5 
binding (Guo et al., 2008). This could explain the growth defects 
displayed by the spt5 sub1Δ and spt4Δ sub1Δ double mutants 
and the correction of the spt5-194 growth defects by overexpress-
ing SUB1.
Based on structural studies, it has been proposed that the 
initiation–elongation transition may become irreversible after 
Spt4/5 binding because Spt4/5 maintains the transcription bubble 
and prevents RNA release (Martinez-Rucobo et al., 2011). On the 
other hand, it has been proposed that initiation factors, such as 
TFIIE, that bind to overlapping sites on the polymerase clamp do-
main (Chen et al., 2007) will likely avoid premature binding of 
Spt4/5 during initiation and therefore Spt5 phosphorylation. It is 
interesting that Sub1 has also been genetically linked to TFIIE, 
and it has been suggested that Sub1 could help TFIIE and TFIIH 
to maintain the open complex (Sikorski et al., 2011). It is possible 
that Sub1 cooperates with TFIIE as a PIC component, where Bur1 
and Spt5 entry is avoided, and with Spt5 as an elongation factor 
to maintain the transcription bubble, depending on Sub1 phos-
phorylation status. In particular, Sub1 could function with Spt5 to 
help stabilize the Rpb1–Spt5 elongation complex and increase 
elongation rate. Furthermore, Sub1 regulates RNAPII and Spt5 
phosphorylation, as shown here and previously (Garcia et al., 
2010), which is required to promote transcription elongation (Bu-
ratowski, 2009; Liu et al., 2009; Zhou et al., 2009). Conversely, the 
effect of Sub1 on in vitro phosphorylation appears to indicate a 
negative effect. It is possible that these negative effects are lim-
ited in vivo to a specific time at which phosphorylation by Bur1 
should be inhibited, for example, during preinitiation (Bur1 is not 
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Numbers on the y-axis of the graphs are detailed in the correspond-
ing figure legend. ChIP analysis to study elongation rate and 
processivity was performed as described (Mason and Struhl, 2005). 
Briefly, to study processivity, yeast cells were grown in rich medium 
with 2% raffinose as the carbon source at 28ºC to an OD600 of 0.5, 
followed by galactose induction for 2.5 h. To study the elongation 
rate, we treated the galactose-induced cells with glucose at a final 
concentration of 5% for 4 min. ChIP was performed three times with 
the 8WG16 antibody using chromatin from three independently 
grown cultures. To represent RNAPII processivity in wild-type and 
mutant cells, the data are expressed as the ratio of RNAPII occu-
pancy in each strain relative to the promoter position followed by 
the normalization of each value to the corresponding position in 
wild-type strain, which was set to 1. To represent the elongation 
rate, the RNAPII association with chromatin after 4 min of glucose 
treatment was normalized to RNAPII association under galactose 
induction conditions at every region tested in the wild-type and 
sub1Δ cells.
Transcriptional run on
Twenty-five milliliters of culture at an OD600 of 0.3–4 growing at 
30ºC and induced with 2% galactose was permeabilized and na-
scent RNA labeled with [α-32P]UTP for 5 min at 30ºC as described 
(Birse et al., 1998; Calvo and Manley, 2001). After partial hydrolysis, 
RNA was hybridized directly to filter immobilized YLR454 probes. 
Hybridization signals were quantitated by PhosphorImager analysis 
(Personal Molecular Imager; Bio-Rad). Each experiment was per-
formed at least three times.
RNA isolation and RT-PCR
Total RNA was extracted as previously described (Schmitt et al., 
1990), and RT-qPCR was performed using the PrimeScript RT 
Reagent Kit (Takara Bio), following the manufacturer’s instructions. 
All qPCRs were performed in triplicate with at least three indepen-
dent cDNA samples.
6-Azauracil induction
Cells were grown in synthetic complete (SC) media without uracil to 
an OD600 of 0.5. They were then split into two cultures, and 6AU 
was added to one of the cultures to a final concentration of 50 or 
100 μg/ml. Both cultures were incubated for 1 h, collected, washed, 
and resuspended in the appropriate buffer to isolate RNA. RT-qPCR 
was performed as described.
GLAM assay
The GLAM assay was carried out as in Morillo-Huesca et al. (2006) 
with cells grown to mid–log phase in selective synthetic medium 
lacking uracil with 2% galactose. Acidic phosphatase activity was 
measured at least twice in cells grown in three to four independently 
induced cultures for each strain. The mean values and standard de-
viations are represented in the corresponding figures.
TAP purification, immunoprecipitation, and Western blot 
analysis
Purification of Sub1-TAP was performed as described (Rodriguez-
Navarro et al., 2004). Sub1-6HA IP was performed as follows: cells 
expressing Sub1-6HA were grown on rich medium to an OD600 
of 1.0, harvested, washed with water, and resuspended in 250 μl 
of lysis buffer (10 mM HEPES-KOH at pH 7.5, 140 mM NaC1, 1 mM 
EDTA, 10% glycerol, 0.1% NP-40, 1 mM phenylmethylsulfonyl fluo-
ride (PMSF), and a cocktail of protease inhibitors). Cell lysis was 
achieved at 4°C using a FastPrep System. The clarified whole-cell 
participates in transcription elongation of constitutively transcribed 
genes (e.g., PMA1), whereas its participation could be very relevant 
for genes whose transcription directly depend on it (e.g., IMD2). For 
instance, the Ccr4–Not1 complex has been recently described as a 
bone fide elongation factor, but it is recruited only to several in-
duced genes (Kruk et al., 2011). In any case, there is ample evidence 
demonstrating that Sub1 is recruited to promoters and associates in 
a transcription-dependent manner with coding regions as part of 
the transcription elongation complex, at least during early elonga-
tion. This is strongly supported by the fact that Sub1 associates with 
the Spt4/Spt5 elongation complex and influences transcription 
elongation rate.
MATERIALS AND METHODS
Yeast strains and media
The strains used in this study are listed in Supplemental Table S1. 
Yeast strain construction and other genetic manipulations were per-
formed following standard procedures (Burke et al., 2000).
In vitro kinase assays
To analyze GST-CTD and 6HIS-Spt5 phosphorylation, we per-
formed in vitro kinase assays as previously described (Garcia et al., 
2010). Cells were grown to an OD600 of 0.8, collected, washed, 
and suspended in lysis buffer (20 mM 4-(2-hydroxyethyl)-1-pipera-
zineethanesulfonic acid [HEPES], pH 7.6, 200 mM KOAc, 10% 
glycerol, 1 mM EDTA; Keogh et al., 2003) containing protease and 
phosphatase inhibitors. Yeast whole-cell extracts were prepared 
by glass bead cell disruption using a FastPrep system. Protein 
concentrations were determined, and 150 μg were incubated with 
15 μl of protein G–Sepharose–coupled 12CA5 (anti-HA) antibody 
for 2 h at 4°C to immunoprecipitate Bur1-HA. The immunoprecipi-
tates were washed three times with lysis buffer and twice with ki-
nase buffer (20 mM HEPES, pH 7.6, 7.5 mM MgOAc, 100 mM 
KOAc, 2% glycerol). The beads were resuspended in 25 μl of 
kinase buffer with 2.5 mM of ATP and incubated with 30 ng of 
GST-CTD or 100 ng of rSpt5 for 30 min at 30°C. The following 
antibodies were used: 8WG16 (nonP-CTD; Covance, Berkeley, 
CA); CTD4H8 (CTD-Ser5P; Millipore, Billerica, MA); anti-Spt5 
(yN-20; Santa Cruz Biotechnology, Santa Cruz, CA), and a phos-
pho-specific anti–Spt5-P antibody (a gift from S. Hahn [Fred 
Hutchinson Cancer Research Center]; Liu et al., 2009). Bur1-HA 
and Bur1-23-HA are C-terminal tagged; however, Bur1-HA is ex-
pressed from a chromosomal copy and Bur1-23-HA from a centro-
meric plasmid (pRS315), both under the control of their own pro-
moters (a gift from S. Buratowski [Harvard Medical School]; see 
Supplemental Table S1).
Chromatin immunoprecipitation
Chromatin purification, immunoprecipitation, RT-qPCR amplifica-
tion, and data analysis were performed as described previously 
(Garcia et al., 2010). Briefly, PCR of purified chromatin, following im-
munoprecipitation, was performed by RT-qPCR with a CFX96 De-
tection System (Bio-Rad, Hercules, CA), using SYBR Premix Ex Taq 
(Takara Bio, Otsu, Japan) and following manufacturer’s instructions. 
Four serial 10-fold dilutions of genomic DNA were amplified using 
the same reaction mixture as the samples to construct the standard 
curves. All real-time PCRs were performed in triplicate and with at 
least three independent ChIPs. Quantitative analysis was carried out 
using the CFX96 Manager Software, version 0.2.1. The values ob-
tained for the IPed PCR products were compared with those of the 
total input, and the ratio of the values from each PCR product from 
transcribed genes to a nontranscribed region of CVII was calculated. 
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extracts (WCEs) were IPed for 2 h at 4°C with anti-HA antibody cou-
pled to protein A–Sepharose. The IPs were extensively washed (lysis 
buffer with 0.5% NP-40) and subsequently resuspended in SDS–
PAGE sample buffer. Western blot analysis was performed using the 
appropriate antibodies. A similar protocol was followed for Spt5-
FLAG IP, although it was performed overnight at 4ºC using anti-
FLAG antibody.
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